- Slimming aid from Hoodia cactus to be developed by Phytopharm and Unilever.
- Production of Hoodia cactus at Phytopharm's nursery will rise from eight million plants to potentially hundreds of millions.
- Phytopharm will receive an initial fee of £6.5m from Unilever, with potential total of £21m and future royalties.
- Unilever will help Phytopharm develop snacks containing Hoodia extract.
- Phytopharm initially hoped to market a slimming drug with Pfizer.
